This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Mixed disorders of conduct and emotions
KRA_PSY_CODUCTEMOT
conduct disorder: A disorder diagnosed in childhood or adolescence age group characterized by aggressive behavior, deceitfulness, destruction of property or violation of rules that is persistent and repetitive, and within a one year period.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1034 |
4. Check minimum number of eventsNone |
1034 |
5. Include endpointsNone |
1034 |
6. Filter based on genotype QC (FinnGen only) |
1034 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F90-F98
- Name in latin
- Perturbationes modi se gerendi et emotionales mixtae
Similar endpoints
↥List of similar endpoints to
Mixed disorders of conduct and emotions
based on the number of shared cases.
Similar with more cases:
- Mixed disorders of conduct and emotions, excluding more controls
- Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
- Any mental disorder
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1034 | 601 | 433 |
| Unadjusted period prevalence (%) | 0.20 | 0.20 | 0.19 |
| Median age at first event (years) | 13.90 | 14.90 | 12.50 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 944
- Matched controls
- 9440
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
2941.1
323.0
356
*
F92.0
ICD-10 Finland
Depressive conduct disorder
10233.1
323.0
513
*
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
+∞
274.8
250
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
9.5
200.6
524
1094
N05AH04
ATC
quetiapine; oral
7.8
167.1
492
1151
F32.9
ICD-10 Finland
Depressive episode, unspecified
6.4
124.6
405
990
N05AX08
ATC
risperidone; systemic
10.4
124.2
266
343
T36
ICD-10 Finland
Poisoning by systemic antibiotics
11.1
112.6
230
267
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
8.4
98.1
237
362
N05AH03
ATC
olanzapine; systemic
7.8
90.8
229
370
F93.89
ICD-10 Finland
Other childhood emotional disorders
13.3
87.3
159
141
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
14.2
86.5
153
127
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
10.4
84.0
174
200
N06AB03
ATC
fluoxetine; oral
6.3
83.1
248
502
F29
ICD-10 Finland
Unspecified nonorganic psychosis
7.6
77.7
198
319
F90.0
ICD-10 Finland
Disturbance of activity and attention
6.3
77.2
231
465
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
10.4
73.7
152
171
N06AX11
ATC
mirtazapine; oral
4.0
72.2
365
1273
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.9
71.0
270
712
N05AX12
ATC
aripiprazole; systemic
7.0
70.8
190
327
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
4.3
69.2
317
1003
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
11.2
68.4
135
139
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
7.8
62.9
154
229
N05BA04
ATC
oxazepam; oral
3.9
62.0
309
1038
F91.9
ICD-10 Finland
Conduct disorder, unspecified
37.4
61.8
79
23
N06BA04
ATC
methylphenidate; oral
6.3
60.1
173
323
N06AB06
ATC
sertraline; oral
4.6
59.7
241
661
N03AG01
ATC
valproic acid; systemic, rectal
6.7
59.2
162
282
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
5.2
58.9
205
480
N06AB04
ATC
citalopram; systemic
4.5
58.5
237
651
N03AX09
ATC
lamotrigine; oral
6.5
56.9
160
288
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
13.1
52.7
95
80
R5599
NOMESCO Finland
Other rehabilitation service
12.3
51.7
96
86
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
3.7
51.3
270
926
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
5.5
48.0
155
328
N05AA02
ATC
levomepromazine; systemic
9.8
46.5
97
109
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
11.4
46.4
89
85
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.4
46.2
184
487
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
8.4
45.9
105
138
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
5.7
45.7
140
278
N06AX16
ATC
venlafaxine; oral
3.8
45.2
221
704
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
23.2
45.0
65
30
B18.2
ICD-10 Finland
Chronic viral hepatitis C
16.6
43.8
71
46
N05AF03
ATC
chlorprothixene; systemic
11.4
43.3
83
79
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
5.4
42.5
137
288
F91.2
ICD-10 Finland
Socialized conduct disorder
57.3
41.8
49
9
N05BA01
ATC
diazepam; systemic, rectal
4.6
41.4
155
383
N06AB10
ATC
escitalopram; oral
2.9
40.5
319
1423
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
13.4
40.1
71
57
F99
ICD-10 Finland
Mental disorder, not otherwise specified
8.1
39.5
92
124
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
9.8
37.2
77
85
N05AH02
ATC
clozapine; systemic
7.8
37.1
88
122
Z63.5
ICD-10 Finland
Disruption of family by separation and divorce
20.1
36.5
55
29
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
11.4
36.2
69
65
R4140
NOMESCO Finland
Psychotherapy
16.1
36.1
59
39
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
7.0
35.4
91
142
F60.9
ICD-10 Finland
Personality disorder, unspecified
12.6
35.4
64
54
N05CF01
ATC
zopiclone; oral
3.3
34.7
196
686
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
7.0
34.5
88
136
C07AA05
ATC
propranolol; systemic
2.9
33.5
243
1009
K04.5
ICD-10 Finland
Chronic apical periodontitis
3.1
32.5
205
774
T74.1
ICD-10 Finland
Physical abuse
6.3
32.4
90
156
IGY02
NOMESCO Finland
Psychiatric monitoring contact
5.1
32.0
107
232
N07BB01
ATC
disulfiram; oral
8.2
31.8
73
96
Z72.2
ICD-10 Finland
Drug use
12.3
31.8
58
50
M79.6
ICD-10 Finland
Pain in limb
2.5
31.7
316
1573
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.8
31.7
111
253
P99
ICPC
Psychological disorders other
5.9
31.3
91
167
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
5.4
30.8
97
196
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
5.0
30.8
104
228
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
4.3
30.3
120
309
RS214
NOMESCO Finland
NA
20.5
30.3
45
23
F20.9
ICD-10 Finland
Schizophrenia, unspecified
9.0
30.2
65
77
IGY99
NOMESCO Finland
Other psychiatric treatment contact
5.2
30.0
98
207
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
13.0
29.3
52
42
P19
ICPC
Drug abuse
7.8
29.2
69
95
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.0
29.0
125
348
P29
ICPC
Psychological sympt/compl other
3.2
28.8
170
609
F90.1
ICD-10 Finland
Hyperkinetic conduct disorder
37.3
28.5
36
10
EB1AA
NOMESCO Finland
Tooth X-ray examination
2.2
28.3
534
3553
X78
ICD-10 Finland
Intentional self-harm by sharp object
12.8
28.0
50
41
Z61.8
ICD-10 Finland
Other negative life events in childhood
15.0
27.7
46
32
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
6.8
27.4
71
112
F39
ICD-10 Finland
Unspecified mood [affective] disorder
6.3
27.3
75
128
N03AE01
ATC
clonazepam; systemic
6.3
27.2
74
125
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
14.2
27.0
46
34
R51.80
ICD-10 Finland
Headache
2.6
27.0
234
1064
Z10.1
ICD-10 Finland
Routine general health check-up of inhabitants of institutions
33.0
27.0
35
11
N06AB05
ATC
paroxetine; oral
5.4
26.9
84
168
F91.1
ICD-10 Finland
Unsocialized conduct disorder
35.2
26.6
34
10
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
8.2
26.6
60
77
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.5
26.4
99
241
IGV01
NOMESCO Finland
Psychiatric network contact
7.3
26.2
64
93
N05AB03
ATC
perphenazine; systemic, rectal
8.2
26.1
59
76
N03AX16
ATC
pregabalin; oral
3.3
26.0
144
489
Z63.2
ICD-10 Finland
Inadequate family support
27.9
25.9
35
13
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
3.1
25.7
157
571
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
9.5
25.5
53
59
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
6.3
25.3
69
117
F43.1
ICD-10 Finland
Post-traumatic stress disorder
4.7
25.0
88
201
EBA00
NOMESCO Finland
Extraction of tooth
2.1
25.0
451
2886
SGA01
NOMESCO Finland
Tooth opening as first aid
2.6
24.5
209
933
P15
ICPC
Chronic alcohol abuse
8.5
24.4
54
67
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
5.6
24.4
73
139
N06AX12
ATC
bupropion; oral
3.2
24.3
136
466
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.7
24.2
113
336
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
4.3
24.0
93
234
N05BA12
ATC
alprazolam; oral
4.5
23.9
88
210
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
23.7
401
2480
L03
ICPC
Low back symptom/complaint
2.3
23.6
264
1356
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.2
23.5
286
1528
WX290
NOMESCO Finland
Other blockade of nerve
2.0
23.5
595
4318
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
11.8
23.4
43
38
AA1AD
NOMESCO Finland
CT of head and brain
3.2
23.2
131
450
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
4.7
23.2
82
188
N05AN01
ATC
lithium; oral
6.5
23.1
61
99
F91.3
ICD-10 Finland
Oppositional defiant disorder
37.3
23.1
29
8
P74
ICPC
Anxiety disorder/anxiety state
3.4
23.1
121
394
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
8.2
23.0
52
67
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
12.6
23.0
41
34
K04.1
ICD-10 Finland
Necrosis of pulp
3.2
22.9
128
437
T51.0
ICD-10 Finland
Toxic effect: Ethanol
10.7
22.8
44
43
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
9.5
22.8
47
52
RS310
NOMESCO Finland
NA
23.6
22.7
32
14
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
21.3
22.7
33
16
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
22.7
222
1065
SAA01
NOMESCO Finland
Simple examination of mouth
2.2
22.5
762
6168
WX110
NOMESCO Finland
Local anesthesy
2.2
22.5
739
5904
M54.5
ICD-10 Finland
Low back pain
2.2
22.4
298
1652
Z35.7
ICD-10 Finland
Supervision of high-risk pregnancy due to social problems
11.9
22.4
41
36
N05CD07
ATC
temazepam; oral
10.2
22.2
44
45
F10.20
ICD-10 Finland
Alcohol dependence currently independent
12.2
22.2
40
34
Z72.0
ICD-10 Finland
Tobacco use
8.7
22.1
48
58
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
10.9
22.0
42
40
N03AX12
ATC
gabapentin; oral
3.7
22.0
103
306
N02AX02
ATC
tramadol; systemic, rectal
2.4
21.7
216
1040
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
6.1
21.6
60
104
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.0
21.5
352
2124
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
21.5
494
3402
F91.0
ICD-10 Finland
Conduct disorder confined to the family context
27.1
21.4
29
11
Z63.8
ICD-10 Finland
Other specified problems related to primary support group
15.1
21.3
35
24
C07AB07
ATC
bisoprolol; oral
2.8
21.3
155
629
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.9
21.0
503
3504
F61.0
ICD-10 Finland
Mixed personality disorders
8.1
20.8
47
61
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.4
20.7
105
333
N02BE01
ATC
paracetamol; systemic, rectal
2.0
20.7
670
5206
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
6.4
20.6
55
91
RS140
NOMESCO Finland
NA
10.9
20.5
39
37
Z71.8
ICD-10 Finland
Other specified counselling
2.1
20.5
314
1836
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
14.6
20.5
34
24
IEV99
NOMESCO Finland
Other psychiatric network intervention
7.7
20.1
47
64
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.8
20.1
88
247
RT420
NOMESCO Finland
NA
19.3
20.0
30
16
N01
ICPC
Headache
2.1
20.0
282
1587
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
9.5
20.0
41
45
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
3.6
19.8
92
272
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
8.2
19.7
44
56
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
4.6
19.7
70
162
F10.09
ICD-10 Finland
Alcohol intoxication UNS
5.7
19.6
57
105
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.1
19.5
114
399
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
9.2
19.3
40
45
F31.8
ICD-10 Finland
Other bipolar affective disorders
5.5
19.2
57
108
XA820
NOMESCO Finland
NA
18.7
19.2
29
16
S18
ICPC
Laceration/cut
2.0
19.1
303
1789
P72
ICPC
Schizophrenia
7.9
18.8
43
57
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.4
18.8
176
819
P01
ICPC
Feeling anxious/nervous/tense
2.1
18.8
277
1587
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
3.8
18.7
83
236
K02.1
ICD-10 Finland
Caries of dentine
1.9
18.7
665
5233
K08.3
ICD-10 Finland
Retained dental root
5.4
18.6
56
108
F51.0
ICD-10 Finland
Nonorganic insomnia
2.5
18.6
165
746
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
13.2
18.5
32
25
P01AB01
ATC
metronidazole; oral, rectal
2.0
18.4
281
1627
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
6.5
18.4
48
77
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
12.2
18.4
33
28
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
18.3
250
1380
-1
NOMESCO Finland
NA
1.8
18.3
494
3518
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
13.9
18.3
31
23
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
18.0
18.3
28
16
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
11.3
18.3
34
31
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
8.0
18.2
41
53
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.6
18.1
84
248
J01DB01
ATC
cefalexin; oral
2.0
18.1
761
6329
N05BA06
ATC
lorazepam; systemic, sublingual
5.9
18.1
51
91
K04.0
ICD-10 Finland
Pulpitis
2.6
18.0
146
627
Z91.5
ICD-10 Finland
Personal history of self-harm
16.9
17.9
28
17
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
8.1
17.9
40
51
N05AD01
ATC
haloperidol; systemic
7.0
17.9
44
65
R11
ICD-10 Finland
Nausea and vomiting
2.8
17.9
120
461
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
4.1
17.8
70
179
SGC00
NOMESCO Finland
Local medication of root channels of tooth
2.7
17.7
129
522
R53
ICD-10 Finland
Malaise and fatigue
2.2
17.6
199
1012
Z72.8
ICD-10 Finland
Other problems related to lifestyle
8.9
17.5
37
43
F21
ICD-10 Finland
Schizotypal disorder
14.2
17.4
29
21
IGP01
NOMESCO Finland
Psychiatric family contact
5.2
17.3
54
109
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
9.5
17.3
35
38
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
7.9
17.2
39
51
F84.8
ICD-10 Finland
Other pervasive developmental disorders
15.1
17.2
28
19
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
12.9
17.2
30
24
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
6.6
17.2
44
69
SPAT1240
SPAT
Therapeutic discussion
2.1
17.1
216
1150
F10.25
ICD-10 Finland
Alcohol dependence continuous use
11.0
17.0
32
30
A01
ICPC
Pain general/multiple sites
3.3
17.0
90
294
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
22.3
16.9
24
11
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
14.4
16.9
28
20
X45
ICD-10 Finland
Accidental poisoning by and exposure to alcohol
11.4
16.8
31
28
P18
ICPC
Medication abuse
10.6
16.8
32
31
F94.1
ICD-10 Finland
Reactive attachment disorder of childhood
35.7
16.7
21
6
L17
ICPC
Foot/toe symptom/complaint
2.0
16.6
241
1359
Z61.7
ICD-10 Finland
Personal frightening experience in childhood
28.1
16.5
22
8
K04.08
ICD-10 Finland
Other specified pulpit
2.8
16.5
109
414
Z61.2
ICD-10 Finland
Altered pattern of family relationships in childhood
20.5
16.5
24
12
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.5
16.5
59
138
RS211
NOMESCO Finland
NA
10.6
16.3
31
30
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
2.6
16.2
123
507
N06BA09
ATC
atomoxetine; oral
13.1
16.2
28
22
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.1
16.1
91
312
SPAT1272
SPAT
Drug screening
8.8
16.1
34
40
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.7
16.0
72
207
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
4.0
16.0
66
176
S06.0
ICD-10 Finland
Concussion
2.4
15.9
151
704
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
2.0
15.8
262
1548
R4170
NOMESCO Finland
Therapy forms involving educational rehabilitation
17.6
15.7
24
14
RS312
NOMESCO Finland
NA
22.5
15.6
22
10
Z72.1
ICD-10 Finland
Alcohol use
9.2
15.5
32
36
F32.8
ICD-10 Finland
Other depressive episodes
5.4
15.5
46
88
A28
ICPC
Limited function/disability NOS
4.0
15.4
62
162
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
4.3
15.3
57
139
N05BA02
ATC
chlordiazepoxide; systemic
29.1
15.2
20
7
P76
ICPC
Depressive disorder
2.5
15.2
125
537
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.3
15.2
157
759
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
6.3
15.1
40
66
R07.4
ICD-10 Finland
Chest pain, unspecified
2.4
15.1
140
641
F60.8
ICD-10 Finland
Other specific personality disorders
14.2
15.1
25
18
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.9
15.0
98
368
N06AX05
ATC
trazodone; oral
6.3
14.8
39
64
N05CF02
ATC
zolpidem; oral
2.7
14.8
109
442
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.1
14.8
180
940
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.7
14.7
104
409
A04
ICPC
Weakness/tiredness general
2.1
14.7
181
945
RS313
NOMESCO Finland
NA
25.5
14.7
20
8
F84.5
ICD-10 Finland
Asperger syndrome
5.4
14.7
44
85
S51.7
ICD-10 Finland
Multiple open wounds of forearm
14.4
14.6
24
17
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
14.6
168
853
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
14.6
144
680
S10
ICPC
Boil/carbuncle
3.4
14.6
72
224
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
11.1
14.6
27
25
IEP99
NOMESCO Finland
Other psychiatric family intervention
6.3
14.5
38
62
Z64.0
ICD-10 Finland
Problems related to unwanted pregnancy
4.0
14.5
58
151
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
6.1
14.5
39
66
N05BE01
ATC
buspirone; oral
5.7
14.5
41
74
WX002
NOMESCO Finland
Sedation and analgesia
2.5
14.5
119
514
SPAT1243
SPAT
Psychiatric/psychological examination
3.0
14.4
84
294
R05
ICPC
Cough
1.9
14.3
254
1534
F34.1
ICD-10 Finland
Dysthymia
3.7
14.3
63
179
KAY40
NOMESCO Finland
NA
0.1
14.2
8
557
R42
ICD-10 Finland
Dizziness and giddiness
2.4
14.2
125
560
R4120
NOMESCO Finland
Occupational therapy
3.4
14.1
68
208
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
2.8
14.0
94
360
L12
ICPC
Hand/finger symptom/complaint
2.1
14.0
184
988
D09
ICPC
Nausea
2.5
14.0
119
522
SPAT1307
SPAT
Psychosocial counselling and guidance
2.1
14.0
189
1025
X84
ICD-10 Finland
Intentional self-harm by unspecified means
9.9
13.8
27
28
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
15.0
13.6
22
15
WX892
NOMESCO Finland
Monitored bed care
3.4
13.6
66
203
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.9
13.5
246
1492
SPAT1265
SPAT
Breathalyser
10.2
13.5
26
26
N06AX21
ATC
duloxetine; oral
2.8
13.5
88
332
XA800
NOMESCO Finland
Neuropsychological investigation
3.4
13.5
65
199
P23
ICPC
Adolescent behaviour sympt/compl
5.9
13.4
37
65
F94.9
ICD-10 Finland
Childhood disorder of social functioning, unspecified
26.2
13.4
18
7
LCH11
NOMESCO Finland
Pharmacologic abortion
2.7
13.3
93
365
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
4.8
13.2
44
96
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
13.2
213
1237
F91.8
ICD-10 Finland
Other conduct disorders
40.7
13.2
16
*
N05AE04
ATC
ziprasidone; systemic
8.0
13.2
29
37
P80
ICPC
Personality disorder
12.4
13.1
23
19
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
2.0
13.1
197
1112
SPAT1234
SPAT
Support of social functional capacity
4.2
13.0
49
121
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
3.8
13.0
56
156
F40.1
ICD-10 Finland
Social phobias
3.1
13.0
73
247
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.7
13.0
92
365
W22
ICD-10 Finland
Striking against or struck by other object(s)
2.5
13.0
109
474
Z50.4
ICD-10 Finland
Psychotherapy, not elsewhere classified
11.8
12.8
23
20
LCH00
NOMESCO Finland
Vacuum aspiration of products of conception from uterus
4.9
12.8
41
86
D10
ICPC
Vomiting
2.2
12.8
139
685
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
4.6
12.7
44
100
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
4.1
12.7
49
124
A29
ICPC
General symptom/complaint other
2.5
12.7
103
441
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.7
12.7
570
4517
F11.20
ICD-10 Finland
Addiction-induced dependence caused by opiates currently independent
15.7
12.6
20
13
RS120
NOMESCO Finland
NA
12.5
12.6
22
18
R74
ICPC
Upper respiratory infection acute
1.7
12.6
443
3278
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
5.2
12.5
38
75
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
9.5
12.5
25
27
R02
ICPC
Shortness of breath/dyspnoea
2.4
12.5
114
518
RT390
NOMESCO Finland
NA
131.7
12.5
13
*
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.4
12.4
107
473
N06BA12
ATC
lisdexamfetamine; oral
8.1
12.4
27
34
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
8.1
12.4
27
34
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
12.4
114
522
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
12.3
143
727
W01
ICPC
Question of pregnancy
4.5
12.3
43
99
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.0
12.3
49
128
D01
ICPC
Abdominal pain/cramps general
2.0
12.2
180
1010
A99
ICPC
Disease/condition unspecnature/site
2.9
12.1
76
280
F19.26
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction
21.6
12.0
17
8
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
12.0
112
515
F10.24
ICD-10 Finland
Alcohol depence active use
10.2
12.0
23
23
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
2.8
12.0
81
310
O35.5
ICD-10 Finland
Maternal care for (suspected) damage to fetus by drugs
13.6
12.0
20
15
F43.25
ICD-10 Finland
Adaptive disorder with mixed mental disorder and behavioral disorder
13.6
12.0
20
15
SPAT1254
SPAT
Administration of medicine
1.9
12.0
192
1110
K04.09
ICD-10 Finland
Pulpit UNS
3.2
11.9
63
207
N06AX03
ATC
mianserin; oral
6.6
11.9
30
47
KMAK
NOMESCO Finland
NA
1.6
11.9
472
3587
KAY20
NOMESCO Finland
NA
0.1
11.9
5
428
R21
ICPC
Throat symptom/complaint
1.7
11.9
378
2706
P06
ICPC
Sleep disturbance
2.2
11.8
126
614
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.8
11.8
50
138
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
11.8
276
1808
F43.00
ICD-10 Finland
Acute stress reaction mild
4.0
11.8
46
118
R03AC02
ATC
salbutamol; inhalant
1.6
11.8
471
3583
M03BC01
ATC
orphenadrine (citrate); systemic
2.0
11.7
169
937
R00.2
ICD-10 Finland
Palpitations
2.8
11.6
76
287
Z61.4
ICD-10 Finland
Problems related to alleged sexual abuse of child by person within primary support group
65.8
11.6
13
*
F60.2
ICD-10 Finland
Dissocial personality disorder
19.2
11.6
17
9
T40.9
ICD-10 Finland
Poisoning: Other and unspecified psychodysleptics [hallucinogens]
23.2
11.6
16
7
E66.01
ICD-10 Finland
Obesity due to excess calories
2.5
11.6
90
377
M54.4
ICD-10 Finland
Lumbago with sciatica
2.3
11.6
108
495
K10.3
ICD-10 Finland
Alveolitis of jaws
3.0
11.5
68
241
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
9.4
11.5
23
25
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
3.1
11.5
62
207
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
7.6
11.5
26
35
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.6
11.4
529
4166
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
12.0
11.4
20
17
EBA15
NOMESCO Finland
Extraction of large number of teeth
5.1
11.3
35
71
R06.0
ICD-10 Finland
Dyspnoea
2.0
11.3
149
799
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
5.8
11.2
31
55
S61.9
ICD-10 Finland
Open wound of wrist and hand, part unspecified
3.7
11.2
49
139
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
17.3
11.2
17
10
A03
ICPC
Fever
1.7
11.2
276
1830
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.1
11.1
136
704
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
8.2
11.1
24
30
Z35.6
ICD-10 Finland
Supervision of very young primigravida
11.3
11.1
20
18
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
11.0
206
1253
Z29
ICPC
Social problem NOS
3.7
11.0
47
131
W14
ICPC
Contraception female other
2.1
11.0
139
730
E66.9
ICD-10 Finland
Obesity, unspecified
3.6
11.0
49
142
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
11.0
182
1060
RS141
NOMESCO Finland
NA
43.8
10.9
13
*
SPAT1283
SPAT
Restricted health certificate
1.6
10.9
347
2470
TKC20
NOMESCO Finland
Catheterisation of bladder
4.2
10.9
41
102
J01FF01
ATC
clindamycin; systemic
1.9
10.9
175
1009
N05AA01
ATC
chlorpromazine; systemic, rectal
12.1
10.9
19
16
SPAT1310
SPAT
Counselling related to known health issue
1.6
10.8
341
2420
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
2.9
10.8
67
245
Z07
ICPC
Education problem
3.9
10.8
44
118
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
2.4
10.8
96
431
P03
ICPC
Feeling depressed
1.9
10.8
189
1121
R1270
NOMESCO Finland
Evaluation of the need for educational rehabilitation
28.4
10.7
14
5
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
21.7
10.7
15
7
R4110
NOMESCO Finland
Physiotherapy
1.9
10.7
175
1015
M54
ICD-10 Finland
Dorsalgia
2.2
10.7
107
508
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
10.6
271
1808
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
8.1
10.6
23
29
A46
ICD-10 Finland
Erysipelas
3.0
10.5
60
207
M25.5
ICD-10 Finland
Pain in joint
1.8
10.5
206
1269
E66.8
ICD-10 Finland
Other obesity
3.4
10.5
51
158
F43.8
ICD-10 Finland
Other reactions to severe stress
3.8
10.5
43
116
R1250
NOMESCO Finland
Evaluation of functional capability
6.0
10.5
28
48
Z62.0
ICD-10 Finland
Inadequate parental supervision and control
111.2
10.4
11
*
G44.2
ICD-10 Finland
Tension-type headache
2.1
10.4
127
656
A05
ICPC
Feeling ill
1.9
10.4
164
937
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.9
10.4
64
233
F41.09
ICD-10 Finland
UNS Panic Syndrome
2.9
10.4
64
233
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
8.3
10.4
22
27
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
8.3
10.4
22
27
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.3
10.3
98
454
Z63.9
ICD-10 Finland
Problem related to primary support group, unspecified
23.6
10.3
14
6
F51.9
ICD-10 Finland
Nonorganic sleep disorder, unspecified
4.8
10.2
33
71
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
6.3
10.2
26
42
F41.00
ICD-10 Finland
Moderate panic disorder
3.9
10.2
41
109
D06
ICPC
Abdominal pain localized other
2.2
10.2
106
512
P17
ICPC
Tobacco abuse
4.9
10.1
32
67
F83
ICD-10 Finland
Mixed specific developmental disorders
3.6
10.1
44
125
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
10.1
207
1292
RT250
NOMESCO Finland
NA
11.4
10.1
18
16
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
6.6
10.1
25
39
J01AA02
ATC
doxycycline; systemic
1.6
10.0
410
3092
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
10.0
144
796
L02
ICPC
Back symptom/complaint
2.1
10.0
120
619
F41.8
ICD-10 Finland
Other specified anxiety disorders
2.9
9.9
61
221
T74.2
ICD-10 Finland
Sexual abuse
16.9
9.9
15
9
F89
ICD-10 Finland
Unspecified disorder of psychological development
16.9
9.9
15
9
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.1
9.8
117
600
F19.30
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated
26.3
9.8
13
5
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.9
9.8
145
809
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
9.8
154
880
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
5.2
9.7
29
57
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.2
9.7
51
168
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
4.0
9.7
38
99
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
13.5
9.7
16
12
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.2
9.6
98
470
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.8
9.6
61
228
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
8.5
9.6
20
24
SGA04
NOMESCO Finland
Very demanding opening and dilatation of root canal of tooth
2.1
9.6
113
577
N04AA02
ATC
biperiden; systemic
6.1
9.6
25
42
S51.9
ICD-10 Finland
Open wound of forearm, part unspecified
6.1
9.6
25
42
K04.7
ICD-10 Finland
Periapical abscess without sinus
3.1
9.5
51
171
SPAT1369
SPAT
Meeting with student welfare group of educational institution
5.0
9.5
29
59
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
5.0
9.5
29
59
Z00.0
ICD-10 Finland
General medical examination
1.8
9.5
194
1209
S51.8
ICD-10 Finland
Open wound of other parts of forearm
6.7
9.5
23
35
RS210
NOMESCO Finland
NA
7.6
9.4
21
28
Z25
ICPC
Assault/harmful event problem
4.8
9.4
30
64
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
8.1
9.4
20
25
F93.1
ICD-10 Finland
Phobic anxiety disorder of childhood
8.1
9.4
20
25
W10
ICD-10 Finland
Fall on and from stairs and steps
3.3
9.2
45
141
RS220
NOMESCO Finland
NA
4.5
9.2
31
70
N06AX26
ATC
vortioxetine; oral
2.3
9.2
83
376
N06AX22
ATC
agomelatine; oral
3.7
9.1
39
110
SPAT1275
SPAT
Drug rehabilitation and replacement therapy of opioid-dependent person
6.3
9.1
23
37
A02BC02
ATC
pantoprazole; systemic
1.6
9.1
335
2445
F43.29
ICD-10 Finland
Adaptation disorder UNS
3.7
9.1
38
105
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.1
9.1
106
540
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
4.8
9.1
29
62
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
11.6
9.1
16
14
F25.11
ICD-10 Finland
Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms
11.6
9.1
16
14
SPAT1227
SPAT
Substance abuse rehabilitation
7.1
9.1
21
30
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
7.1
9.1
21
30
Z03
ICPC
Housing/neighbourhood problem
9.1
9.0
18
20
F40.2
ICD-10 Finland
Specific (isolated) phobias
4.9
9.0
28
58
L15
ICPC
Knee symptom/complaint
1.8
9.0
168
1014
N17
ICPC
Vertigo/dizziness
2.2
9.0
91
435
F43.24
ICD-10 Finland
Adaptive disorder with behavioral disorder
18.8
8.9
13
7
P98
ICPC
Psychosis NOS/other
5.8
8.9
24
42
Z62.2
ICD-10 Finland
Institutional upbringing
24.3
8.9
12
5
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
4.5
8.9
30
68
Z00.8
ICD-10 Finland
Other general examinations
2.1
8.9
98
488
P28
ICPC
Limited function/disability (P)
6.9
8.9
21
31
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
8.8
129
716
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
3.0
8.8
50
172
RT130
NOMESCO Finland
NA
10.8
8.8
16
15
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
9.6
8.8
17
18
F22.0
ICD-10 Finland
Delusional disorder
9.6
8.8
17
18
103
Kela drug reimbursment
Diabetes, insulin-treated
2.2
8.8
88
419
W79
ICPC
Unwanted pregnancy
3.0
8.8
50
173
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.8
8.8
166
1006
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
4.3
8.7
31
74
J01CE02
ATC
phenoxymethylpenicillin; oral
1.6
8.7
692
6008
F81.0
ICD-10 Finland
Specific reading disorder
4.6
8.7
29
65
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
6.2
8.6
22
36
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.5
8.6
66
276
A11
ICPC
Chest pain NOS
3.0
8.6
49
170
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
2.0
8.6
112
596
Z02.4
ICD-10 Finland
Examination for driving licence
2.5
8.6
65
269
F19.09
ICD-10 Finland
Intoxication caused by several drugs in combination and by other psychoactive substances UNS
16.5
8.6
13
8
F25.21
ICD-10 Finland
Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms
16.5
8.6
13
8
N07BA03
ATC
varenicline; oral
3.0
8.5
47
161
F82
ICD-10 Finland
Specific developmental disorder of motor function
4.1
8.5
32
81
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
6.1
8.5
22
37
F88
ICD-10 Finland
Other disorders of psychological development
7.4
8.5
19
26
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
2.8
8.4
53
196
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
3.6
8.4
36
102
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
4.5
8.4
28
63
Z61.5
ICD-10 Finland
Problems related to alleged sexual abuse of child by person outside primary support group
12.9
8.4
14
11
N76.0
ICD-10 Finland
Acute vaginitis
2.1
8.4
98
498
L16
ICPC
Ankle symptom/complaint
1.9
8.4
127
714
A27
ICPC
Fear of other disease NOS
3.2
8.4
42
135
Y07
ICD-10 Finland
Other maltreatment
6.3
8.3
21
34
M79.1
ICD-10 Finland
Myalgia
2.0
8.3
114
618
N06AB08
ATC
fluvoxamine; oral
8.6
8.3
17
20
T90
ICPC
Diabetes non-insulin dependent
3.0
8.3
47
162
IER01
NOMESCO Finland
Psychoeducation, group
4.8
8.3
26
55
F11.30
ICD-10 Finland
Withdrawal symptoms caused by opiates uncomplicated
14.6
8.2
13
9
R40.2
ICD-10 Finland
Coma, unspecified
14.6
8.2
13
9
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
3.4
8.2
38
115
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
7.6
8.2
18
24
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
7.6
8.2
18
24
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.8
8.2
52
195
R2110
NOMESCO Finland
Giving the first information
2.5
8.1
62
257
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
8.1
221
1488
WYA50
NOMESCO Finland
Student oral health check consistent with decree to assess need for oral health guidance and services
0.4
8.1
32
778
Y34
ICD-10 Finland
Unspecified event, undetermined intent
8.2
8.1
17
21
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.8
8.1
51
189
WZA90
NOMESCO Finland
Other doctors statement
1.6
8.1
270
1919
N06AA12
ATC
doxepin; systemic
5.6
8.0
22
40
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
4.5
8.0
27
62
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.6
8.0
58
235
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.4
8.0
67
293
S01
ICPC
Pain/tenderness of skin
2.9
7.9
46
163
Z30.8
ICD-10 Finland
Other contraceptive management
2.4
7.9
67
295
IDR03
NOMESCO Finland
Systematic group therapy, dialectical behaviour therapy (DBT)
7.8
7.9
17
22
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
7.8
7.9
17
22
Y09
ICD-10 Finland
Assault by unspecified means
6.2
7.9
20
33
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.1
7.8
84
413
SPAT1301
SPAT
No procedures
1.5
7.8
288
2087
IEY02
NOMESCO Finland
Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)
8.5
7.8
16
19
RS110
NOMESCO Finland
NA
10.9
7.8
14
13
F32
ICD-10 Finland
Depressive episode
2.2
7.8
76
356
SFA40
NOMESCO Finland
Replacement of krone of tooth
2.2
7.8
81
392
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
9.5
7.8
15
16
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
7.0
7.8
18
26
S29
ICPC
Skin symptom/complaint other
1.8
7.8
148
899
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
1.9
7.8
124
708
E66
ICD-10 Finland
Obesity
3.0
7.8
44
152
H01
ICPC
Ear pain/earache
1.7
7.7
165
1037
SGC10
NOMESCO Finland
Covering pulpa of tooth
1.8
7.7
136
805
P22
ICPC
Child behaviour symptom/complaint
4.1
7.7
28
69
RT260
NOMESCO Finland
NA
45.3
7.7
9
*
TQX20
NOMESCO Finland
Implantation of subcutaneous medicament implant
5.6
7.7
21
38
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
7.7
135
797
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
5.0
7.6
23
47
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
8.1
7.6
16
20
N05AD03
ATC
melperone; systemic
18.5
7.6
11
6
F94.8
ICD-10 Finland
Other childhood disorders of social functioning
12.0
7.6
13
11
RT230
NOMESCO Finland
NA
25.2
7.6
10
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.8
7.6
45
163
F60.0
ICD-10 Finland
Paranoid personality disorder
8.9
7.6
15
17
J01CA04
ATC
amoxicillin; systemic
1.9
7.5
864
8046
S61.7
ICD-10 Finland
Multiple open wounds of wrist and hand
5.8
7.5
20
35
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
10.1
7.5
14
14
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
2.8
7.5
48
180
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.0
7.5
100
535
IEY01
NOMESCO Finland
Psychoeducation, individual
4.2
7.5
27
66
L86
ICPC
Back syndrome with radiating pain
3.4
7.5
34
102
LCH13
NOMESCO Finland
Vacuum aspiration from uterus after medically induced abortion
4.5
7.5
25
57
F43.0
ICD-10 Finland
Acute stress reaction
2.5
7.5
58
244
Z32.1
ICD-10 Finland
Pregnancy confirmed
1.7
7.5
162
1021
F44.88
ICD-10 Finland
Other definite dissociation disorder
80.7
7.4
8
*
O26.88
ICD-10 Finland
Other specified pregnancy-related conditions
3.6
7.4
31
87
D11
ICPC
Diarrhoea
1.7
7.4
154
960
Z11
ICPC
Compliance/being ill problem
13.5
7.4
12
9
F43.9
ICD-10 Finland
Reaction to severe stress, unspecified
3.1
7.4
39
131
F41
ICD-10 Finland
Other anxiety disorders
3.5
7.4
33
98
RD210
NOMESCO Finland
NA
2.9
7.3
42
147
-2
ICD-10 Finland
NA
0.2
7.3
7
347
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
7.3
312
2334
P16
ICPC
Acute alcohol abuse
4.1
7.3
27
68
X14
ICPC
Vaginal discharge
2.6
7.3
51
203
W02
ICPC
Fear of pregnancy
5.0
7.3
22
45
SPAT1244
SPAT
Occupational therapy
11.0
7.3
13
12
F61.1
ICD-10 Finland
Disturbing personality change
+∞
7.3
7
*
Z27
ICPC
Fear of a social problem
5.5
7.2
20
37
F50.9
ICD-10 Finland
Eating disorder, unspecified
3.2
7.2
36
116
F19.9
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder
15.9
7.2
11
7
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.4
7.2
62
274
R50.9
ICD-10 Finland
Fever, unspecified
1.7
7.2
143
879
N03AF02
ATC
oxcarbazepine; oral
2.8
7.2
44
163
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.7
7.2
158
999
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
4.9
7.2
22
46
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
7.2
46
174
M03BX02
ATC
tizanidine; oral
1.5
7.1
348
2674
Z61.6
ICD-10 Finland
Problems related to alleged physical abuse of child
20.2
7.1
10
5
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.5
7.1
53
218
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
3.6
7.1
30
85
SPAT1262
SPAT
Handing over of treatment supplies
2.1
7.1
81
410
F32.1
ICD-10 Finland
Moderate depressive episode
2.0
7.1
89
467
J20
ICD-10 Finland
Acute bronchitis
2.1
7.1
74
360
R44.0
ICD-10 Finland
Auditory hallucinations
12.1
7.1
12
10
F19.2
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome
12.1
7.1
12
10
XF600
NOMESCO Finland
Bloodpressure measurement
2.3
7.1
62
279
SPAT1395
SPAT
Health check-up of persons outside student and working life
4.4
7.1
24
56
XMA22
NOMESCO Finland
General examination of pregnant woman
2.3
7.1
64
292
M53.1
ICD-10 Finland
Cervicobrachial syndrome
2.2
7.1
72
348
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.3
7.1
61
271
TPH07
NOMESCO Finland
Cathetrisation of artery
2.5
7.0
52
212
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
10.1
7.0
13
13
F90.8
ICD-10 Finland
Other hyperkinetic disorders
10.1
7.0
13
13
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
3.0
7.0
40
139
A97
ICPC
No disease
1.6
7.0
183
1214
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
7.0
128
767
R03BA05
ATC
fluticasone; inhalant
1.6
7.0
176
1159
A10BA02
ATC
metformin; oral
2.2
7.0
66
307
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
7.0
73
356
Z73.8
ICD-10 Finland
Other problems related to life-management difficulty
5.5
6.9
19
35
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
4.7
6.9
22
48
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
13.9
6.9
11
8
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.6
6.9
225
1581
SPAT1389
SPAT
Visit based on need for special support
1.9
6.8
97
534
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
8.3
6.8
14
17
S00.7
ICD-10 Finland
Multiple superficial injuries of head
6.8
6.8
16
24
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
6.8
6.8
16
24
F80.2
ICD-10 Finland
Receptive language disorder
3.8
6.8
27
73
P77
ICPC
Suicide/suicide attempt
11.0
6.8
12
11
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
5.4
6.8
19
36
Y04.8
ICD-10 Finland
Assault by bodily force by other known person
5.7
6.8
18
32
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
6.8
131
799
F80.1
ICD-10 Finland
Expressive language disorder
3.1
6.8
34
111
Z62.8
ICD-10 Finland
Other specified problems related to upbringing
16.8
6.8
10
6
L18
ICPC
Muscle pain
2.7
6.7
43
162
SPAT1281
SPAT
Other administrative function
1.9
6.7
92
501
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.9
6.7
94
517
B86
ICD-10 Finland
Scabies
2.9
6.7
39
140
WX402
NOMESCO Finland
General anaesthesia
1.7
6.7
130
795
K59.0
ICD-10 Finland
Constipation
2.6
6.7
47
189
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
6.6
561
4776
R96
ICPC
Asthma
2.2
6.6
68
328
X58
ICD-10 Finland
Exposure to other specified factors
1.7
6.6
145
915
K59.1
ICD-10 Finland
Functional diarrhoea
2.6
6.6
44
172
Z04.0
ICD-10 Finland
Blood-alcohol and blood-drug test
12.3
6.6
11
9
F12.5
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, psychotic disorder
12.3
6.6
11
9
RS221
NOMESCO Finland
NA
4.4
6.6
22
51
F43.23
ICD-10 Finland
Adaptive disorder with other mental disorder
6.9
6.5
15
22
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
5.1
6.5
19
38
S80.0
ICD-10 Finland
Contusion of knee
2.1
6.5
76
386
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.1
6.5
33
109
L02.1
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of neck
6.2
6.5
16
26
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
5.4
6.5
18
34
J35.2
ICD-10 Finland
Hypertrophy of adenoids
1.9
6.5
101
573
R12
ICD-10 Finland
Heartburn
2.2
6.4
62
290
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.1
6.4
69
339
Z30.2
ICD-10 Finland
Sterilization
2.6
6.4
43
169
IHA03
SPAT
NA
14.4
6.4
10
7
ZXA05
NOMESCO Finland
Left side
1.8
6.3
100
570
M03BC51
ATC
orphenadrine, combinations; systemic
1.7
6.3
138
870
F23.90
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
8.2
6.3
13
16
EBA30
NOMESCO Finland
Excision of root of tooth
3.5
6.3
27
78
Z63.4
ICD-10 Finland
Disappearance and death of family member
5.2
6.3
18
35
N05AX13
ATC
paliperidone; systemic
5.2
6.3
18
35
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.7
6.3
119
721
WX730
NOMESCO Finland
Conventional respirator
5.6
6.3
17
31
IEY21
NOMESCO Finland
Other intensified psychiatric treatment
5.6
6.3
17
31
S69.9
ICD-10 Finland
Unspecified injury of wrist and hand
3.2
6.3
31
100
R33
ICD-10 Finland
Retention of urine
3.9
6.3
24
63
R44.3
ICD-10 Finland
Hallucinations, unspecified
11.1
6.3
11
10
F63.0
ICD-10 Finland
Pathological gambling
9.3
6.3
12
13
JN4BD
NOMESCO Finland
Extensive body CT
2.9
6.3
36
127
Z61.1
ICD-10 Finland
Removal from home in childhood
18.1
6.3
9
5
N30.0
ICD-10 Finland
Acute cystitis
1.8
6.3
118
711
K59.09
ICD-10 Finland
Constipation, unspecified
2.8
6.3
38
141
SPD01
NOMESCO Finland
Mucosa-supported complete denture
+∞
6.3
6
*
O35.4
ICD-10 Finland
Maternal care for (suspected) damage to fetus from alcohol
26.9
6.2
8
*
IEP01
NOMESCO Finland
Psychoeducation, family
7.1
6.2
14
20
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
6.2
42
166
F31
ICD-10 Finland
Bipolar affective disorder
4.0
6.2
23
59
G47.3
ICD-10 Finland
Sleep apnoea
2.1
6.2
70
353
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
3.8
6.2
24
64
L01
ICPC
Neck symptom/complaint
1.7
6.2
124
761
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
2.7
6.2
40
152
J01EA01
ATC
trimethoprim; systemic
1.6
6.2
153
998
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
3.4
6.2
27
80
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.8
6.1
37
137
K05.31
ICD-10 Finland
Periodontitis pronounced
3.6
6.1
25
70
A03FA01
ATC
metoclopramide; systemic, rectal
1.8
6.1
98
563
F94.0
ICD-10 Finland
Elective mutism
12.6
6.1
10
8
Z61.9
ICD-10 Finland
Negative life event in childhood, unspecified
12.6
6.1
10
8
D72
ICPC
Viral hepatitis
12.6
6.1
10
8
QCB00
NOMESCO Finland
Suture of skin of upper limb
4.9
6.1
18
37
S61.8
ICD-10 Finland
Open wound of other parts of wrist and hand
3.0
6.1
32
109
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
1.6
6.1
149
973
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
5.2
6.0
17
33
JN5BD
NOMESCO Finland
Head and body CT examination for trauma
6.1
6.0
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028707) Methadone [Presence] in Urine by Screen method
272
599
5.80
122.30
7.4
3.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
307
996
3.96
81.91
8.3
2.9
—
—
—
0
0
(4198724)
101
131
8.44
74.26
3.9
2.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
377
1540
3.28
68.76
2.5
1.7
%
1.5
1.3
8.63
337
1404
(1001926) Buprenorphine [Presence] in Urine by Screen method
310
1146
3.44
66.27
6.9
2.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
491
2387
3.01
65.35
3.7
3.0
u/l
31.6
28.8
1.14
468
2265
(3016879) Cocaine [Presence] in Urine
335
1362
3.16
60.43
6.6
2.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
388
1729
2.99
59.33
7.3
3.8
mmol/l
8.7
9.1
0.45
340
1554
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
462
2281
2.85
58.11
7.0
6.2
mmol/l
1.2
1.2
0.18
436
2093
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
521
2747
2.81
57.61
5.0
4.8
umol/l
9.3
10.4
1.58
485
2535
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
735
4645
3.01
57.12
6.5
5.8
u/l
77.8
77.0
0.19
690
4353
(3000764) Benzodiazepines [Presence] in Urine
338
1450
2.98
54.67
6.6
2.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
486
2530
2.74
54.23
7.1
6.3
mmol/l
1.2
1.2
0.00
423
2167
(44816559) Phosphatidylethanol [Mass/volume] in Blood
125
275
5.03
54.18
1.5
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
339
1463
2.96
54.16
6.5
2.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
339
1464
2.96
54.08
6.7
2.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
85
147
6.21
47.75
6.6
5.1
umol/l
394.3
377.2
0.41
74
129
(3027944) Amphetamines [Presence] in Urine
322
1435
2.81
47.55
6.1
2.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
63
83
8.02
45.43
11.2
10.4
mmol/l
0.6
0.6
0.09
56
76
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
288
1241
2.83
45.03
2.5
2.1
u/l
200.3
279.4
0.63
271
1187
(3023103) Potassium [Moles/volume] in Serum or Plasma
925
7110
3.86
43.19
14.2
7.7
mmol/l
3.9
3.9
0.08
905
6806
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
53
60
9.26
43.12
1.8
1.7
iu/ml
668982.0
710666.4
—
8
11
(3018418) pH of Serum or Plasma
311
1425
2.69
42.88
3.3
3.2
ph
7.4
7.4
0.01
64
267
(3019550) Sodium [Moles/volume] in Serum or Plasma
923
7096
3.80
42.83
14.3
7.7
mmol/l
139.6
139.5
1.08
906
6817
(40758558) Short blood count panel - Blood
363
1821
2.53
41.26
8.5
7.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
185
651
3.24
41.17
1.6
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
587
3662
2.39
40.81
5.7
4.3
mmol/l
6.3
6.1
1.67
539
3186
(3044889) 12 lead EKG panel
579
3629
2.35
39.28
3.1
2.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
267
1191
2.67
38.31
4.3
3.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
359
1881
2.39
36.23
1.7
1.5
pmol/l
99.5
97.5
0.36
201
1075
(3013650) Neutrophils [#/volume] in Blood by Automated count
655
4423
2.31
35.97
14.9
8.5
e9/l
4.3
3.9
5.06
570
3847
(3015377) Calcium [Moles/volume] in Serum or Plasma
324
1631
2.44
35.69
2.2
2.4
mmol/l
2.4
2.4
0.27
296
1470
(3001604) Monocytes [#/volume] in Blood
591
3916
2.19
32.74
8.4
6.7
e9/l
0.6
0.5
5.25
512
3420
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
335
1770
2.32
32.56
3.2
2.5
u/l
48.3
55.5
4.31
305
1631
(3006315) Basophils [#/volume] in Blood
591
3924
2.18
32.46
8.4
6.7
e9/l
0.0
0.0
1.04
512
3425
(3013115) Eosinophils [#/volume] in Blood
602
4047
2.17
31.76
10.0
7.2
e9/l
0.2
0.2
0.02
533
3609
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
814
6225
2.45
30.68
4.7
3.6
pmol/l
14.4
14.5
0.69
771
5689
(42870588) Differential panel, method unspecified - Blood
429
2563
2.15
30.35
7.1
7.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
747
5524
2.27
30.23
4.3
2.7
u/l
38.0
27.7
6.26
716
5301
(3022096) Basophils/100 leukocytes in Blood
548
3597
2.11
30.22
8.4
6.9
%
0.6
0.6
0.83
512
3383
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
888
7114
2.76
29.53
5.7
4.1
mu/l
1.7
1.9
0.51
849
6733
(3019150) Specific gravity of Urine by Refractometry
328
1779
2.24
29.45
4.1
2.9
kg/l
1.0
1.0
0.22
32
261
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
830
6473
2.43
28.72
10.5
6.2
ml/min/173m2
111.3
107.8
5.23
626
4819
(3019069) Monocytes/100 leukocytes in Blood
560
3765
2.06
28.27
8.5
6.9
%
8.0
8.0
0.09
523
3556
(3006504) Eosinophils/100 leukocytes in Blood
556
3733
2.06
28.12
8.2
6.7
%
2.5
2.8
1.81
517
3496
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
47
77
6.35
27.73
2.2
1.6
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
30
29
10.62
27.22
4.0
3.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
221
1044
2.42
27.15
1.4
1.3
nmol/l
16.7
18.7
1.63
205
935
(3019198) Lymphocytes [#/volume] in Blood
599
4169
2.04
26.98
8.6
6.5
e9/l
2.2
2.0
4.00
528
3735
(3020191) Ethanol [Moles/volume] in Serum or Plasma
50
91
5.72
26.52
1.7
1.2
promille
1.3
1.4
0.23
41
66
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
77
202
4.04
26.38
2.4
2.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
365
2138
2.09
26.38
4.2
5.2
g/l
37.8
38.2
0.81
341
1973
(3002582) Erythrocytes [#/volume] in Urine
334
1898
2.12
26.11
3.4
3.0
e6/l
25.5
56.1
1.14
254
1423
(3030467) Casts [#/volume] in Urine by Automated count
313
1737
2.15
26.01
3.3
3.0
e6/l
0.2
0.2
0.35
233
1279
(3014111) Lactate [Moles/volume] in Serum or Plasma
120
426
3.06
25.80
8.6
6.9
mmol/l
1.3
1.5
0.56
110
401
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
362
2131
2.08
25.68
3.7
3.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
533
3600
1.99
25.67
10.9
8.2
e9/l
0.0
0.0
1.25
419
2876
(3020564) Creatinine [Moles/volume] in Serum or Plasma
945
8002
3.10
24.79
13.2
7.9
umol/l
67.7
68.6
0.38
945
7997
(3019309) Folate [Moles/volume] in Red Blood Cells
153
633
2.66
24.71
1.6
1.5
nmol/l
1143.0
1059.1
0.56
126
491
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
785
6134
2.16
24.56
4.1
2.4
mmol/l
5.8
5.4
6.20
740
5712
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
268
1427
2.19
24.55
2.9
2.1
ng/l
25.7
265.7
0.52
106
472
(3002030) Lymphocytes/100 leukocytes in Blood
573
4024
1.95
24.04
8.3
6.5
%
31.0
31.7
0.81
535
3810
(3018010) Neutrophils/100 leukocytes in Blood
564
3955
1.94
23.60
8.1
6.4
%
54.7
54.5
0.16
527
3745
(36304419) Bacteria [Presence] in Urine
312
1785
2.07
23.55
3.2
3.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
955
8193
3.17
23.26
10.5
7.0
u/l
31.8
26.8
4.46
936
7893
(3021447) Carbon dioxide [Partial pressure] in Venous blood
140
588
2.60
21.82
4.4
7.2
kpa
6.0
5.9
0.26
135
572
(3018095) Leukocytes [#/volume] in Urine
391
2475
1.93
21.79
4.1
3.4
e6/l
54.0
53.3
0.01
265
1546
(3002032) Base excess in Venous blood by calculation
139
583
2.60
21.72
5.8
7.3
mmol/l
1.4
1.4
0.06
114
468
(3013707) Erythrocyte sedimentation rate by Westergren method
676
5112
1.93
21.70
3.7
3.4
mm/h
8.0
7.0
2.00
628
4746
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
30
40
7.69
21.30
3.2
2.9
umol/l
144.2
172.4
0.18
15
21
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
195
965
2.26
21.08
2.8
2.7
e6/l
7.8
3.6
2.18
97
508
(3000991) Gas panel - Venous blood
129
532
2.63
20.83
9.8
9.5
—
—
—
0
0
(3015736) pH of Urine
454
3050
1.87
20.82
4.0
2.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
310
1843
1.97
20.56
2.9
2.1
—
—
—
0
0
(3026782) Osmolality of Urine
228
1224
2.11
19.99
2.7
2.6
mosm/kgh2o
547.6
580.7
1.05
197
1046
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
21
19
11.26
19.82
1.2
1.2
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
23
24
9.78
19.72
4.9
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
326
1996
1.92
19.68
2.2
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
193
982
2.19
19.37
2.7
2.7
e6/l
0.9
0.9
0.00
96
526
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
122
507
2.59
19.36
1.7
1.7
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
124
520
2.57
19.31
4.3
7.1
kpa
5.2
5.0
0.64
118
506
(3032080) INR in Blood by Coagulation assay
276
1614
1.97
18.98
3.7
4.1
inr
1.0
1.1
1.73
116
591
(3027801) Oxygen [Partial pressure] in Arterial blood
96
356
2.87
18.98
10.4
8.6
kpa
12.8
15.2
4.30
89
338
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
96
356
2.87
18.98
10.4
8.6
kpa
5.1
5.0
0.37
89
337
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
122
516
2.55
18.65
1.8
1.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
233
1292
2.04
18.59
2.7
2.6
e6/l
13.9
8.5
0.70
199
1126
(3003396) Base excess in Arterial blood by calculation
95
356
2.84
18.42
10.5
8.6
mmol/l
0.2
0.2
0.03
74
263
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
935
8145
2.55
18.11
14.5
8.7
mg/l
20.3
20.5
0.06
755
5920
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
415
2803
1.80
17.98
2.7
2.5
nmol/l
60.0
67.3
6.96
390
2646
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
161
785
2.24
17.86
1.9
1.8
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
53
143
3.85
17.45
1.7
3.3
ug/l
192.7
250.5
0.34
46
131
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
21
23
9.30
17.36
10.3
11.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
135
619
2.36
17.28
2.3
2.2
u/l
23.0
35.6
3.66
109
515
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
669
5269
1.76
16.36
4.4
3.0
mmol/mol
37.3
35.9
2.18
631
5006
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
26
41
6.48
15.88
1.7
2.0
umol/l
13.7
17.2
0.89
26
41
(3002385) Erythrocyte distribution width [Ratio]
868
7454
2.02
15.50
20.5
10.9
%
13.2
13.1
3.07
857
7288
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
164
851
2.10
15.44
2.4
1.9
—
—
—
0
0
(3013512) EKG study
191
1059
1.99
14.96
2.9
2.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
633
4988
1.69
14.65
5.4
3.7
e6/l
680.5
170.7
0.52
13
47
(3010421) pH of Blood
48
139
3.57
14.29
4.8
3.2
ph
7.4
7.4
0.12
40
120
(3024928) Oxygen saturation in Venous blood
39
99
4.05
13.98
3.1
6.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
509
3820
1.65
13.94
3.3
2.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
155
817
2.06
13.92
3.2
2.6
ng/l
195.8
875.2
1.51
58
349
(3022217) INR in Platelet poor plasma by Coagulation assay
76
294
2.71
13.86
4.1
8.8
inr
1.1
1.1
0.31
14
69
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
209
1230
1.88
13.60
3.1
2.5
u/l
15053.9
6657.4
1.09
75
492
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
221
1324
1.85
13.60
1.6
1.5
mmol/l
1.7
1.3
3.17
200
1206
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
102
461
2.35
13.42
7.4
7.6
mmol/l
23.9
23.8
0.04
95
437
(3012095) Magnesium [Moles/volume] in Serum or Plasma
143
744
2.07
13.28
4.4
6.4
mmol/l
0.8
0.8
0.36
133
703
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
55
184
3.10
13.04
12.1
11.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
159
867
1.99
12.95
1.6
1.4
pmol/l
83453636.5
23784928.6
0.49
139
761
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
105
490
2.27
12.81
4.4
2.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
59
209
2.93
12.67
14.1
9.4
%
93.2
94.6
0.96
59
209
(3012501) Base excess in Blood by calculation
42
121
3.58
12.61
4.9
3.1
mmol/l
1.6
2.0
0.54
27
66
(40767503) Oxygen content in Capillary blood by calculation
36
94
3.93
12.43
2.8
2.4
%
17.2
18.4
0.72
16
46
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
468
3523
1.60
12.07
3.0
2.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
646
5303
1.58
11.09
4.8
3.7
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
53
193
2.84
10.85
14.2
9.0
mmol/l
23.7
23.7
0.04
47
184
(3007853) Bacteria identified in Skin by Aerobe culture
155
889
1.87
10.78
1.8
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
40
124
3.32
10.77
4.6
3.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
142
792
1.92
10.75
1.8
1.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
201
1250
1.75
10.70
1.8
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
59
231
2.65
10.53
1.7
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
76
337
2.35
10.44
1.6
1.5
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
15
21
7.23
10.15
11.2
4.6
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
28
71
4.03
10.08
2.4
1.9
mmol/l
1.6
1.9
0.63
28
71
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
130
719
1.92
10.07
2.8
3.7
umol/l
4.6
6.2
1.35
102
578
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
108
560
2.04
10.06
1.7
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
97
485
2.10
9.96
2.5
3.4
g/l
0.2
0.2
0.22
90
456
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
123
672
1.94
9.88
1.7
2.1
mmol/l
2.4
2.4
1.36
100
570
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
223
1456
1.68
9.88
2.0
2.5
mg/l
0.9
0.9
0.15
154
953
(3020682) Albumin/Creatinine [Ratio] in Urine
144
836
1.84
9.59
5.1
4.8
mg/mmol
19.9
16.3
0.14
101
641
(3018677) aPTT in Platelet poor plasma by Coagulation assay
137
784
1.86
9.55
2.7
3.7
s
29.4
29.7
0.36
131
766
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
87
425
2.14
9.49
6.3
5.8
mmol/l
1.4
1.1
0.48
55
297
(3009343) pH of Capillary blood
87
429
2.12
9.26
6.3
5.8
ph
7.4
7.4
1.42
13
36
(3012516) Albumin [Mass/volume] in Urine
139
810
1.83
9.14
4.3
4.0
mg/l
605.1
105.7
0.51
101
629
(3016650) Hepatitis A virus Ab [Presence] in Serum
50
194
2.66
9.11
1.2
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
753
6536
1.56
9.00
3.5
2.5
mmol/l
2.8
2.8
0.19
701
6180
(3020891) Body temperature
38
128
3.04
8.96
4.0
5.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
750
6535
1.54
8.52
3.4
2.5
mmol/l
4.5
4.5
1.61
711
6230
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
28
81
3.53
8.41
1.1
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
74
356
2.16
8.40
3.8
2.6
mmol/l
1.2
1.2
0.38
68
300
(36660697) Celiac disease serology panel - Serum
158
980
1.72
8.37
1.2
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
361
2728
1.50
8.29
1.5
1.4
u/ml
0.9
1.7
1.41
81
643
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
743
6485
1.52
8.15
3.3
2.5
mmol/l
1.3
1.4
17.86
697
6166
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
48
194
2.55
8.08
1.9
1.9
ug/l
3.9
7.0
1.11
39
165
(21494755) Public health laboratory ask at order entry panel
67
1300
0.48
7.91
1.1
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
96
520
1.93
7.90
7.4
4.3
%
0.5
0.6
0.24
22
121
(3019060) Gas panel - Arterial blood
43
169
2.61
7.67
4.8
7.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
46
187
2.53
7.67
1.2
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
26
78
3.39
7.42
3.8
6.9
%
64.4
66.8
0.22
26
78
(3000963) Hemoglobin [Mass/volume] in Blood
1001
9519
2.62
7.33
25.4
12.6
g/l
137.8
137.8
0.00
993
9399
(3011397) Hemoglobin [Presence] in Urine by Test strip
241
1710
1.53
7.33
3.5
2.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
290
2140
1.49
7.32
2.2
2.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1000
9513
2.56
7.17
24.8
12.5
e12/l
4.7
4.7
0.09
973
9255
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
91
501
1.90
7.14
5.8
3.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
929
8623
1.76
7.05
13.7
7.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
166
1090
1.62
7.03
1.3
1.2
iu/ml
11.3
15.7
1.61
37
264
(3010813) Leukocytes [#/volume] in Blood
1000
9520
2.53
7.03
24.9
12.6
e9/l
7.4
6.8
16.74
972
9258
(3035941) MCH [Entitic mass]
999
9510
2.49
6.95
24.7
12.5
pg
29.7
29.7
0.03
991
9392
(3007461) Platelets [#/volume] in Blood
998
9497
2.46
6.94
25.0
12.6
e9/l
268.6
260.4
3.98
974
9244
(3024731) MCV [Entitic volume]
999
9511
2.49
6.93
24.7
12.5
fl
88.5
88.3
1.06
991
9392
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
75
393
1.98
6.81
1.4
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
244
1765
1.50
6.71
2.3
2.3
mg/l
2.9
2.5
1.72
217
1529
(3021440) Promyelocytes/100 leukocytes in Blood
90
506
1.85
6.63
7.8
4.3
%
0.0
0.0
1.23
19
116
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
307
2331
1.45
6.59
2.7
2.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
535
4490
1.40
6.47
2.8
2.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
121
749
1.70
6.43
2.0
2.0
nmol/l
350.2
396.5
1.82
107
690
(3002179) Metamyelocytes/100 leukocytes in Blood
87
490
1.85
6.38
5.8
3.9
%
0.3
0.4
0.19
15
94
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
256
1889
1.47
6.34
2.4
2.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
86
486
1.84
6.24
8.1
4.4
%
0.0
0.1
0.73
15
100
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
94
546
1.79
6.24
3.9
4.1
ng/l
1321.2
747.1
0.37
70
397
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
52
1014
0.49
6.17
1.3
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
73
394
1.92
6.10
1.4
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
160
1077
1.57
6.08
1.4
1.4
titre
428.6
511.2
0.22
14
173
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
697
6152
1.41
6.07
3.1
2.4
mmol/l
1.3
1.1
6.89
654
5867
(3035350) Ketones [Presence] in Urine by Test strip
463
3822
1.38
6.04
3.8
2.9
estimate
0.0
0.0
0.80
109
784
(3019225) pH of Specimen
74
404
1.90
5.98
5.3
2.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
270
2038
1.44
5.89
3.8
3.0
estimate
0.0
0.0
0.80
108
797
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
33
745
0.42
5.82
1.4
1.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
123
791
1.63
5.65
2.7
2.4
g/l
2.6
2.5
0.49
113
722
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
26
93
2.84
5.60
2.7
1.7
ug/l
4.3
4.5
0.01
26
76
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
11
21
5.28
5.53
4.5
2.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
303
2360
1.40
5.49
1.5
1.5
g/l
1.9
2.0
0.24
143
1436
(3021901) Oxygen saturation in Capillary blood
23
78
2.99
5.44
2.5
4.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
149
1012
1.55
5.43
1.3
1.2
u/ml
12.9
7.2
0.33
48
388
(3052851) Hemolysis interference index of Serum or Plasma
37
162
2.33
5.33
2.4
2.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
456
3807
1.35
5.33
5.0
4.0
estimate
0.0
0.0
0.00
115
823
(3009261) Glucose [Presence] in Urine by Test strip
459
3841
1.35
5.26
3.8
2.9
estimate
0.0
0.0
0.50
112
800
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
419
3460
1.35
5.23
4.5
4.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
66
366
1.86
5.12
1.7
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
418
3466
1.35
5.03
2.3
1.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
109
710
1.60
4.76
2.8
2.5
%
22.6
24.6
0.81
95
634
(3022948) Iron [Moles/volume] in Serum or Plasma
128
872
1.53
4.60
2.6
2.4
umol/l
14.4
15.2
0.56
120
804
(3000494) Fungus identified in Specimen by Culture
107
700
1.59
4.59
1.4
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
202
2615
0.72
4.29
2.2
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
214
1638
1.39
4.18
2.2
2.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
118
807
1.52
4.17
1.7
1.6
mu/l
429.3
304.5
2.12
104
717
(3017446) Testosterone [Moles/volume] in Serum or Plasma
102
678
1.56
4.10
2.1
2.0
nmol/l
10.0
11.9
1.02
90
608
(40761535) Cells panel - Urine sediment
65
385
1.73
4.10
3.4
2.8
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
31
142
2.22
4.08
1.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
31
142
2.22
4.08
1.2
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
85
542
1.62
4.07
2.6
3.5
pmol/l
4.7
4.9
0.58
77
483
(3036180) Methadone [Presence] in Urine
7
7
10.06
4.01
2.0
2.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
46
248
1.89
3.94
1.7
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
96
642
1.55
3.77
1.1
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
16
55
2.94
3.75
2.9
1.8
mosm/kgh2o
294.0
288.4
0.36
11
41
(3016018) Differential panel - Cerebral spinal fluid
23
96
2.43
3.74
1.3
2.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
74
472
1.61
3.57
3.5
1.7
e9/l
4.3
4.2
0.27
66
421
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
51
846
0.58
3.56
1.8
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
55
328
1.71
3.43
2.5
4.3
e9/l
70.2
71.6
0.06
41
220
(3007566) Smooth muscle Ab [Titer] in Serum
42
231
1.85
3.42
1.3
1.5
titre
52.9
75.2
—
7
23
(3030981) Hyaline casts [#/volume] in Urine by Automated count
41
224
1.86
3.41
2.6
2.4
e6/l
0.5
0.1
0.79
41
215
(3009542) Hematocrit [Volume Fraction] of Blood
893
8468
1.40
3.41
17.2
9.6
%
40.7
40.8
0.09
716
7291
(40761536) Microorganisms panel - Urine sediment
110
776
1.47
3.37
3.9
3.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
417
3601
1.26
3.33
2.1
1.8
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
38
206
1.88
3.25
1.3
2.2
e6/l
40.0
23.3
0.32
27
155
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
38
206
1.88
3.25
1.3
2.2
e6/l
103622.1
108.2
0.50
29
164
(3044290) Cell count panel - Cerebral spinal fluid
37
199
1.89
3.24
1.3
2.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
13
44
2.98
3.14
3.5
9.6
%
11.3
12.3
0.31
13
44
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
12
39
3.10
3.09
1.4
1.1
%
94.8
91.8
—
5
21
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
16
5.03
3.05
1.9
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
54
332
1.66
3.04
2.2
2.1
ml/min/173m2
84.9
92.0
0.44
14
105
(3030905) Polymorphonuclear cells [#/volume] in Blood
32
168
1.93
3.02
3.3
3.6
e9/l
3.3
3.6
0.64
32
168
(3027945) Reticulocytes/100 erythrocytes in Blood
76
511
1.53
2.96
4.4
5.5
%
1.7
1.6
0.35
67
466
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
32
170
1.91
2.93
3.9
3.8
%
52.4
53.4
0.16
32
170
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
17
4.73
2.92
1.9
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
17
4.73
2.92
1.9
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
49
297
1.68
2.92
2.6
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
245
2013
1.28
2.87
7.0
3.8
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
12
41
2.95
2.86
1.4
1.0
%
91.6
93.9
—
5
23
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
17
71
2.42
2.81
1.1
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
343
2944
1.25
2.78
3.7
2.8
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
53
333
1.62
2.77
8.2
5.7
mmol/l
23.7
24.3
0.88
53
327
(3022313) Gas panel - Capillary blood
53
342
1.58
2.51
8.6
6.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
7
16
4.40
2.47
1.0
1.0
—
—
—
0
0
(4010399)
51
329
1.58
2.42
1.3
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
34
197
1.75
2.41
2.0
3.5
ng/l
23.5
110.3
2.86
26
162
(3028026) IgM [Mass/volume] in Serum or Plasma
70
486
1.47
2.38
1.7
1.9
g/l
1.1
1.1
0.07
64
444
(3023410) Appearance of Cerebral spinal fluid
20
97
2.08
2.38
1.2
3.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
484
4357
1.21
2.38
3.1
2.9
ug/l
72.4
62.1
1.05
447
4094
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
8
6.27
2.37
1.2
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
17
4.14
2.36
1.0
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
89
648
1.41
2.36
1.1
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
53
348
1.55
2.34
1.7
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
829
8648
0.79
2.30
4.2
4.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
52
770
0.66
2.29
1.5
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
52
342
1.55
2.29
2.1
1.8
ug/l
1.3
0.9
0.23
41
309
(3026493) Urate [Moles/volume] in Serum or Plasma
132
1029
1.32
2.29
2.6
2.7
umol/l
335.7
3425.0
2.50
119
940
(3022621) pH of Urine by Test strip
64
443
1.47
2.23
3.5
2.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
220
1838
1.25
2.22
1.7
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
121
1.92
2.22
1.7
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
149
1846
0.77
2.20
1.6
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
48
2.52
2.19
1.6
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
41
258
1.61
2.18
5.4
4.9
g/l
0.2
0.3
0.47
24
154
(3035320) C reactive protein [Mass/volume] in Body fluid
14
61
2.31
2.15
1.9
1.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
19
95
2.02
2.11
1.2
1.3
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
26
146
1.80
2.08
3.0
2.6
nmol/l
0.9
0.8
0.23
21
125
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
57
392
1.48
2.06
2.0
1.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
22
118
1.88
2.02
1.6
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
180
2156
0.80
2.00
1.6
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
41
617
0.65
1.98
2.3
2.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
13
57
2.30
1.98
4.1
2.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
21
3.35
1.96
2.3
7.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
15
72
2.10
1.87
1.4
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
84
638
1.34
1.77
2.2
2.9
g/l
10.2
10.3
0.07
76
577
(3004809) Band form neutrophils/100 leukocytes in Blood
16
81
1.99
1.75
3.4
3.2
%
1.8
1.0
0.30
11
63
(3023323) Follitropin [Units/volume] in Serum or Plasma
76
571
1.36
1.73
1.4
1.6
iu/l
7.6
9.0
0.49
59
443
(3035285) Chloride [Moles/volume] in Venous blood
7
24
2.93
1.72
2.4
2.0
mmol/l
108.3
106.9
—
7
24
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
24
2.93
1.72
7.0
6.3
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
7
24
2.93
1.72
2.4
2.0
mmol/l
3.9
3.8
—
7
24
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
13
3.86
1.71
1.2
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
89
1.93
1.70
8.6
12.8
u/ml
0.3
0.4
—
7
56
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
180
0.44
1.69
1.0
1.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
42
2.39
1.68
1.0
1.0
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
50
351
1.45
1.68
1.7
1.6
nmol/l
36.2
38.3
0.21
50
346
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
76
1.99
1.65
1.7
1.9
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
80
612
1.33
1.63
1.6
1.7
u/l
6.0
6.8
0.62
67
488
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
14
3.58
1.61
1.8
1.3
ug/l
8.5
8.0
—
5
14
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
14
3.58
1.61
3.4
6.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
39
563
0.68
1.58
1.8
1.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
18
309
0.58
1.55
1.1
1.1
u/ml
5.8
6.1
—
6
136
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
33
2.44
1.54
1.6
2.2
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
5
15
3.34
1.52
1.8
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
15
3.34
1.52
1.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
21
2.87
1.50
1.0
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
56
411
1.38
1.49
1.3
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
102
820
1.27
1.46
1.1
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
12
59
2.05
1.44
1.2
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
22
2.74
1.43
2.7
2.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
46
329
1.42
1.43
7.1
6.2
ng/l
94.9
62.1
0.82
46
305
(3032773) Endomysium IgG Ab [Titer] in Serum
20
118
1.71
1.42
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
38
263
1.46
1.40
1.4
1.2
—
—
—
0
0
(4024509)
9
40
2.26
1.40
1.7
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
101
816
1.26
1.40
1.5
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
57
426
1.36
1.38
1.1
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
22
135
1.64
1.36
1.2
1.3
ug/g
243.4
380.3
—
8
56
(3034274) Bile acid [Moles/volume] in Serum --fasting
56
420
1.35
1.33
3.4
2.5
umol/l
5.2
5.9
0.20
45
322
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
27
176
1.55
1.32
2.5
2.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
54
404
1.36
1.31
1.4
1.5
u/ml
201.8
192.3
0.15
37
233
(4146454)
6
24
2.51
1.30
3.8
2.8
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
38
268
1.43
1.29
1.4
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
36
2.23
1.24
1.0
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
36
2.23
1.24
1.0
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
36
2.23
1.24
1.0
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
38
271
1.42
1.23
1.4
1.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
16
93
1.73
1.21
1.1
1.3
—
49.3
—
0
6
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
23
148
1.57
1.21
2.0
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
26
2.32
1.19
1.3
1.4
nmol/l
106.3
115.7
—
6
26
(3036489) Thrombin time
44
325
1.37
1.17
2.8
4.4
s
20.4
21.4
1.68
37
280
(3008898) HLA-B27 [Presence]
62
483
1.30
1.17
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
35
249
1.42
1.16
1.9
2.1
iu/l
4.8
5.0
0.04
14
105
(3002619) Bacteria identified in Specimen by Culture
5
20
2.51
1.15
1.0
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
180
1578
1.17
1.12
2.5
2.8
ug/g
112.2
111.5
0.01
132
1231
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
58
1.91
1.12
1.6
1.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
12
66
1.83
1.09
1.3
1.3
pmol/l
532.6
290.0
—
7
49
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
29
202
1.45
1.08
1.2
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
32
2.20
1.08
2.1
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
18
113
1.60
1.06
1.6
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
82
1.72
1.05
1.1
1.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
37
272
1.37
1.04
1.2
1.6
nmol/l
0.3
0.4
0.93
32
237
(3010726) Horse dander IgE Ab [Units/volume] in Serum
29
404
0.71
1.03
1.0
1.1
u/ml
2.7
2.6
—
5
110
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
75
1.74
1.03
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
75
1.74
1.03
1.2
1.1
—
—
—
0
0
(4034850)
25
171
1.47
1.03
17.2
7.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
16
99
1.63
1.00
1.2
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
7
35
2.01
1.00
1.0
1.1
—
4.3
—
0
6
(3023419) Bacteria identified in Sputum by Culture
7
35
2.01
1.00
3.0
9.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
17
107
1.60
1.00
1.9
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
76
1.72
0.99
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
76
1.72
0.99
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
76
1.72
0.99
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
76
1.72
0.99
1.2
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
23
156
1.49
0.99
1.2
1.4
u/ml
4.2
4.3
0.05
13
77
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
49
1.84
0.98
1.9
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
25
173
1.46
0.98
3.5
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
350
3241
1.12
0.98
2.2
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
362
3359
1.12
0.97
1.8
1.9
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
7
36
1.95
0.97
1.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
85
1.66
0.94
1.6
1.4
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
6
27
2.23
0.93
1.5
1.2
—
68.9
—
0
8
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
70
1.72
0.93
1.6
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
19
126
1.52
0.91
1.8
1.2
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
6
28
2.15
0.91
1.5
1.1
—
84.3
—
0
8
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
42
323
1.31
0.91
1.7
1.6
iu/ml
12.5
0.2
—
8
64
(43055514) Macroprolactin [Presence] in Serum or Plasma
11
63
1.75
0.90
1.2
1.1
—
—
—
0
0
(3000492) Spirometry study
88
742
1.20
0.88
1.3
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
13
79
1.65
0.88
1.2
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
24
169
1.43
0.88
1.2
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
30
2.01
0.87
1.0
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
44
1.82
0.86
1.0
1.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
8
44
1.82
0.86
6.3
4.0
umol/l
23.3
25.7
—
8
44
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
26
187
1.40
0.85
1.8
2.5
g/l
1.5
1.2
0.52
21
170
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
80
1.63
0.85
1.3
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
76
904
0.83
0.84
1.6
1.6
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
31
1.94
0.84
1.2
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
20
138
1.46
0.82
1.2
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
13
81
1.61
0.81
1.2
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
24
172
1.40
0.81
1.1
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
32
416
0.76
0.78
1.0
1.1
u/ml
1.0
1.2
0.13
18
217
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
14
91
1.55
0.75
1.4
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
37
469
0.78
0.75
1.1
1.2
u/ml
0.5
1.9
2.41
16
223
(40768804) Tissue Pathology biopsy report
245
2257
1.11
0.75
1.8
1.7
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
39
1.80
0.72
2.0
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
56
1.61
0.72
1.1
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
60
1.67
0.72
1.2
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
40
1.75
0.71
1.0
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
7
41
1.71
0.70
3.4
3.9
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
9
58
1.56
0.70
1.1
1.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
19
135
1.42
0.69
1.1
1.2
—
1.7
—
0
8
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
20
144
1.40
0.68
1.4
1.6
mmol/l
14.8
10.9
—
5
13
(3003888) Timothy IgE Ab [Units/volume] in Serum
34
429
0.79
0.68
1.0
1.1
u/ml
5.5
7.7
0.43
20
272
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
15
102
1.48
0.67
1.1
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
43
1.63
0.67
2.0
4.6
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
94
0.53
0.67
1.0
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
99
869
1.15
0.66
1.3
1.2
iu/ml
156.8
145.0
0.09
33
312
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
23
171
1.35
0.66
1.1
1.1
iu/ml
21.6
139.2
—
5
60
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
25
189
1.33
0.65
2.3
2.6
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
16
112
1.44
0.63
1.1
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
21
280
0.74
0.63
1.0
1.1
u/ml
5.7
7.7
—
6
135
(3022145) Colonoscopy Study observation
67
572
1.18
0.63
1.5
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
71
1.56
0.62
1.0
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
30
1.67
0.61
1.0
1.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
10
151
0.66
0.60
1.7
1.6
%
12.9
12.9
—
10
151
(40768446) Kidney Pathology biopsy report
8
52
1.54
0.59
1.6
1.9
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
39
318
1.24
0.59
1.1
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
13
89
1.47
0.58
5.0
4.0
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
81
1.49
0.57
1.2
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
247
2310
1.09
0.56
3.3
2.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
36
1.67
0.56
2.3
1.6
pg
26.7
32.1
—
6
36
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
88
0.57
0.56
1.4
2.6
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
6
37
1.63
0.55
1.0
1.0
u/ml
1.9
0.6
—
6
29
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
99
1.42
0.54
1.7
1.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
170
0.70
0.53
1.2
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
91
1020
0.88
0.53
1.5
1.5
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
6
39
1.54
0.53
1.2
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
83
1.45
0.52
1.2
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
83
1.45
0.52
1.2
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
83
1.45
0.52
1.2
3.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
9
64
1.41
0.51
2.2
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
31
252
1.24
0.50
3.4
2.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
20
257
0.77
0.49
1.2
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
46
1.53
0.48
1.0
1.3
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
7
46
1.53
0.48
1.3
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
23
181
1.28
0.48
1.7
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
109
1200
0.90
0.48
1.4
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
17
128
1.33
0.48
1.0
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
47
1.49
0.47
2.3
1.5
—
—
—
0
0
(4306422)
18
137
1.32
0.47
1.1
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
20
255
0.78
0.47
1.2
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
27
218
1.24
0.47
2.8
2.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
48
1.46
0.47
1.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
81
0.62
0.46
1.2
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
18
138
1.31
0.45
1.0
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
55
479
1.16
0.45
1.1
1.2
—
42.7
—
0
13
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
14
104
1.35
0.43
1.1
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
87
1.38
0.42
1.7
1.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
95
0.63
0.42
1.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
57
1.41
0.42
1.0
1.1
iu/ml
231.3
199.3
—
8
57
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
20
158
1.27
0.42
1.1
1.4
u/ml
2.5
6.6
—
6
70
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
40
466
0.85
0.42
1.6
1.6
mg/l
3.7
3.8
0.03
30
292
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
20
249
0.80
0.40
1.7
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
27
325
0.83
0.40
1.2
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
21
168
1.26
0.40
1.3
1.4
ug/l
0.3
0.5
—
10
57
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
19
150
1.27
0.40
1.4
1.7
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.7
—
17.8
—
0
6
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
27
224
1.21
0.38
2.2
1.9
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
114
0.70
0.37
1.9
1.8
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
69
1.31
0.37
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
69
1.31
0.37
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
72
1.39
0.37
1.1
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
72
1.39
0.37
2.5
4.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
37
319
1.17
0.36
1.7
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
42
1.43
0.35
1.7
2.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
42
1.43
0.35
1.3
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
80
0.62
0.35
1.4
1.6
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
6
43
1.40
0.35
1.3
1.3
—
71.3
—
0
6
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
42
477
0.88
0.33
1.2
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
10
74
1.35
0.32
1.0
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
47
1.28
0.32
2.3
2.3
—
—
—
0
0
(4211845)
6
47
1.28
0.32
1.7
2.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
11
83
1.33
0.32
1.1
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
11
84
1.31
0.30
1.1
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
77
709
1.09
0.29
1.5
1.3
miu/ml
185.0
245.2
0.62
18
348
(3036071) Salmonella sp Ab [Titer] in Serum
7
57
1.23
0.29
1.1
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
48
431
1.12
0.28
1.7
1.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
173
0.81
0.28
1.0
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
35
308
1.14
0.28
1.7
1.6
u/ml
100.1
96.9
—
5
50
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
104
1.25
0.26
1.2
1.1
—
—
—
0
0
(1002224) Polysomnography panel
33
291
1.14
0.26
1.1
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
87
1.27
0.24
1.1
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
10
78
1.28
0.24
2.2
2.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
78
1.28
0.24
1.8
1.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
58
533
1.09
0.24
2.9
2.2
%
31.8
31.9
0.02
48
408
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
23
199
1.16
0.23
2.4
1.9
—
—
—
0
0
(4268621)
14
115
1.22
0.23
1.9
2.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
87
927
0.93
0.23
1.5
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
39
1.28
0.23
2.2
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
39
1.28
0.23
3.4
1.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
5
39
1.28
0.23
1.8
3.5
—
1288.8
—
0
5
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
5
39
1.28
0.23
1.2
1.2
g/l
0.3
0.3
—
5
32
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
5
40
1.25
0.22
1.0
1.1
—
16.4
—
0
8
(3024471) HLA-A [Type]
5
40
1.25
0.22
1.2
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
87
925
0.94
0.22
1.5
1.5
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
5
41
1.22
0.22
3.0
1.3
nmol/l
1.1
1.4
—
5
33
(3011841) English Walnut IgE Ab [Units/volume] in Serum
5
41
1.22
0.22
1.0
1.0
u/ml
11.5
0.8
—
5
34
(3020874) Milk IgE Ab [Units/volume] in Serum
10
124
0.80
0.21
1.1
1.1
u/ml
0.1
2.7
—
5
53
(3006598) pH of Arterial cord blood
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
54.5
—
0
6
(3022670) pH of Venous cord blood
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
5.7
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
12.6
—
0
12
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
3.6
—
17.3
—
0
13
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
9.5
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
3.5
—
4.2
—
0
13
(3005322) IgE [Units/volume] in Serum or Plasma
72
674
1.07
0.20
1.4
1.3
u/ml
177.1
340.1
1.27
66
622
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
48
1.25
0.20
1.0
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
48
1.25
0.20
2.5
3.4
—
—
—
0
0
(4094501)
6
48
1.25
0.20
1.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
12
99
1.21
0.19
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
30
333
0.90
0.19
1.6
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
88
930
0.94
0.19
1.5
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
88
929
0.94
0.19
1.5
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
109
1.20
0.18
1.5
1.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
29
261
1.11
0.18
1.1
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
18
157
1.15
0.17
1.1
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
68
0.73
0.17
1.6
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
68
1.18
0.16
1.0
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
68
1.18
0.16
1.0
1.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
70
1.14
0.16
1.0
1.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
12
102
1.18
0.15
1.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
83
1.09
0.14
1.2
1.1
—
—
—
0
0
(44790049)
8
96
0.83
0.13
1.0
1.8
—
—
—
0
0
(44806118)
8
96
0.83
0.13
1.0
1.8
—
—
—
0
0
(44790048)
8
96
0.83
0.13
1.0
1.8
—
—
—
0
0
(44790047)
8
96
0.83
0.13
1.0
1.8
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
24
263
0.91
0.13
1.5
1.7
mmol/l
7.3
7.3
0.01
13
161
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
9
108
0.83
0.13
7.3
5.5
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
9
108
0.83
0.13
3.7
2.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
58
550
1.06
0.13
1.6
1.2
—
—
—
0
0
(44813793)
10
85
1.18
0.12
1.0
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
86
1.16
0.11
2.4
3.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
16
144
1.11
0.10
2.8
2.6
mg/l
21.9
24.7
0.16
11
93
(4062490)
11
96
1.15
0.10
1.2
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
154
1.11
0.10
1.5
1.8
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
47
1.06
0.09
1.6
3.4
u/ml
697.2
846.7
—
5
47
(40768441) Liver Pathology biopsy report
5
48
1.04
0.09
1.2
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
56
1.07
0.08
1.0
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
56
1.07
0.08
2.7
3.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
58
1.03
0.08
1.2
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
62
0.81
0.08
12.2
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
10
88
1.14
0.08
1.0
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
113
1104
1.03
0.07
1.8
2.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
76
1.05
0.07
1.3
1.0
miu/ml
2135.9
1382.0
—
8
76
(3029396) Erythrocyte agglutination [Presence] in Blood
9
84
1.07
0.07
3.4
3.2
—
—
—
0
0
(4027681)
10
89
1.12
0.07
1.3
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
79
811
0.97
0.06
1.4
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
11
121
0.91
0.06
1.0
1.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
30
287
1.05
0.05
12.9
13.6
mg/l
1.5
1.1
1.68
30
275
(3005033) Fetal Nuchal fold Thickness US
72
735
0.98
0.04
1.6
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
28
270
1.04
0.03
1.2
1.1
—
—
—
0
0
(4035726)
30
310
0.97
0.03
1.9
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
29
299
0.97
0.02
1.4
1.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
33
338
0.98
0.01
1.1
1.0
—
4.6
—
0
48
(3047352) Trisomy 18 risk [Likelihood] in Fetus
73
739
0.99
0.01
1.6
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
76
753
1.01
0.01
1.6
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
106
1.04
0.00
1.1
1.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
12
124
0.97
0.00
3.2
4.4
u/ml
4.2
6.8
0.60
12
95
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
37
374
0.99
0.00
1.5
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
38
378
1.01
0.00
1.8
2.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
21
209
1.00
0.00
1.0
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
3.6
—
0.6
—
0
5
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
1.4
—
0
5
(3029612) Listeria sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
49.6
—
0
5
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
5.0
—
4.4
—
0
5
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
7
0.00
0.00
0.0
9.9
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
8
0.00
0.00
0.0
1.3
—
70.8
—
0
8
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
57
0.88
0.00
1.6
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
53
0.94
0.00
1.4
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
24.4
—
0
6
(3021788) Differential panel - Synovial fluid
6
66
0.91
0.00
1.2
1.9
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
49
1.02
0.00
1.4
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
9.8
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
7
0.00
0.00
0.0
1.3
—
33.6
—
0
7
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
6
66
0.91
0.00
1.7
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
63
0.95
0.00
1.3
1.0
—
—
—
0
0
(3000936) Kiwifruit IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
1.1
—
0
6
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
67
0.89
0.00
1.2
1.2
nmol/l
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: KRA_PSY_CODUCTEMOT – Mixed disorders of conduct and emotions
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).